Carl Atkinson Selected Research

Complement Factor B (Factor B)

11/2012	The alternative complement pathway propagates inflammation and injury in murine ischemic stroke.
6/2012	Complement-dependent injury and protection in a murine model of acute dextran sulfate sodium-induced colitis.
12/2010	The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury.
7/2010	Murine complement deficiency ameliorates acute cigarette smoke-induced nasal damage.
1/2010	Alterations in gene expression of complement components in chronic rhinosinusitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carl Atkinson Research Topics

Disease

21	Inflammation (Inflammations) 01/2021 - 05/2004
20	Reperfusion Injury 10/2021 - 09/2005
13	Ischemia 10/2021 - 09/2005
7	Rhinosinusitis 01/2022 - 01/2010
7	Neoplasms (Cancer) 01/2021 - 08/2008
6	Infections 01/2022 - 05/2004
6	Brain Death (Brain Dead) 01/2021 - 04/2003
4	Nasal Polyps (Nasal Polyp) 01/2022 - 07/2011
4	Wounds and Injuries (Trauma) 01/2021 - 09/2006
4	Spinal Cord Injuries (Spinal Cord Injury) 01/2017 - 09/2006
4	Brain Ischemia (Cerebral Ischemia) 12/2015 - 11/2006
4	Infarction (Infarctions) 12/2015 - 04/2002
3	Lung Injury 01/2022 - 01/2019
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 04/2014
3	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2021 - 12/2018
3	Emphysema 01/2019 - 02/2005
3	Necrosis 07/2018 - 05/2010
3	Hereditary Complement Deficiency Diseases 12/2015 - 07/2010
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2015 - 02/2012
3	Ischemic Stroke 11/2012 - 11/2006
2	Pneumonia (Pneumonitis) 01/2022 - 04/2014
2	Primary Graft Dysfunction 01/2022 - 01/2021
2	Hypoxia (Hypoxemia) 11/2021 - 11/2011
2	Autoimmune Diseases (Autoimmune Disease) 11/2021 - 01/2008
2	Macular Degeneration (Age-Related Maculopathy) 04/2016 - 05/2014
2	Stroke (Strokes) 12/2015 - 11/2006
2	Demyelinating Diseases (Demyelinating Disease) 11/2012 - 12/2010
2	Allergic Fungal Sinusitis 07/2011 - 01/2010
2	Urinary Bladder Neoplasms (Bladder Cancer) 09/2008 - 08/2008
2	Thrombosis (Thrombus) 11/2006 - 04/2002
2	Bronchiolitis 10/2006 - 05/2004
2	Familial Primary Pulmonary Hypertension 12/2003 - 04/2002
1	Asthma (Bronchial Asthma) 01/2022
1	Hemolysis 01/2022
1	Invasive Pulmonary Aspergillosis 01/2022
1	Hemorrhage 01/2022
1	Aspergillosis 01/2022
1	Starvation 01/2022
1	Death (Near-Death Experience) 10/2021
1	Opportunistic Infections (Opportunistic Infection) 01/2021
1	Vascular System Injuries 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Edema (Dropsy) 12/2020
1	Leukemia 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018

Drug/Important Bio-Agent (IBA)

34	Complement System Proteins (Complement)IBA 10/2021 - 04/2002
11	Complement Inactivating AgentsIBA 10/2021 - 09/2005
8	Proteins (Proteins, Gene)FDA Link 11/2012 - 09/2005
6	Immunoglobulin M (IgM)IBA 10/2021 - 09/2008
6	CytokinesIBA 12/2020 - 04/2002
6	SmokeIBA 01/2019 - 11/2009
5	AntibodiesIBA 10/2021 - 08/2008
5	Complement Factor B (Factor B)IBA 11/2012 - 01/2010
4	P-SelectinIBA 01/2021 - 05/2005
3	Immunoglobulin G (IgG)IBA 01/2022 - 08/2008
3	Cholecalciferol (Vitamin D3)FDA Link 01/2022 - 08/2014
3	AutoantibodiesIBA 01/2022 - 01/2019
2	hydroxide ionIBA 01/2022 - 01/2017
2	Prostaglandins DIBA 01/2022 - 01/2021
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 04/2002
2	Protein Kinases (Protein Kinase)IBA 11/2021 - 04/2014
2	EpitopesIBA 10/2021 - 01/2019
2	MicroRNAs (MicroRNA)IBA 12/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 07/2017 - 01/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2014 - 01/2010
2	ChemokinesIBA 03/2013 - 07/2011
2	LectinsIBA 11/2012 - 06/2012
2	Complement 3d Receptors (Complement Receptor 2)IBA 06/2012 - 09/2005
2	Toll-Like Receptor 4IBA 09/2011 - 09/2009
2	Clodronic Acid (Clodronate)IBA 09/2011 - 05/2010
2	Transaminases (Aminotransferases)IBA 09/2011 - 05/2010
2	Complement C3 (C3 Complement)IBA 01/2008 - 12/2007
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 05/2005 - 04/2002
1	Calcifediol (Calcidiol)FDA Link 01/2022
1	ElastinIBA 01/2022
1	Polysaccharides (Glycans)IBA 01/2022
1	Hemeproteins (Heme Protein)IBA 01/2022
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2022
1	CollagenIBA 01/2022
1	Heme (Haem)IBA 01/2022
1	IronIBA 01/2022
1	Adenosine Monophosphate (AMP)IBA 11/2021
1	ERRalpha Estrogen-Related ReceptorIBA 11/2021
1	Sterol Regulatory Element Binding ProteinsIBA 11/2021
1	Sirolimus (Rapamycin)FDA Link 11/2021
1	Transcription Factors (Transcription Factor)IBA 11/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	complement C3a receptorIBA 10/2018
1	Mitochondrial Permeability Transition PoreIBA 01/2018
1	C-Reactive ProteinIBA 07/2017
1	LeptinIBA 07/2017
1	Bronchodilator Agents (Bronchodilators)IBA 07/2017

Therapy/Procedure

8	Transplantation 01/2021 - 05/2005
7	Therapeutics 11/2021 - 02/2005
6	Lung Transplantation 01/2021 - 05/2004
4	Heart Transplantation (Grafting, Heart) 10/2021 - 04/2003
2	Organ Transplantation 01/2015 - 12/2010
1	Cell Transplantation 12/2018
1	Kidney Transplantation 01/2018